Page last updated: 2024-10-22

albuterol and Adjustment Disorders

albuterol has been researched along with Adjustment Disorders in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Adjustment Disorders: Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Simon, P1
Lecrubier, Y1
Jouvent, R1
Puech, AJ1
Allilaire, JF1
Widlöcher, D1

Trials

1 trial available for albuterol and Adjustment Disorders

ArticleYear
Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant.
    Psychological medicine, 1978, Volume: 8, Issue:2

    Topics: Adjustment Disorders; Adult; Albuterol; Bipolar Disorder; Clinical Trials as Topic; Depression; Huma

1978